Showing 4891-4900 of 5646 results for "".
- Lineage Cell Therapeutics Reports Regeneration of Retinal Tissue in Patient Treated With OpRegen RPE Cells for Dry AMD With GAhttps://modernod.com/news/lineage-cell-therapeutics-reports-regeneration-of-retinal-tissue-in-patient-treated-with-opregen-rpe-cells-for-dry-amd-with-ga/2477845/Lineage Cell Therapeutics announced that restoration of retinal tissue was observed in a patient enrolled in a phase 1/2a study of its lead product candidate, OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy in development for the treatment of dry age-related macular degenerati
- Can You Catch COVID-19 Through Your Eyes?https://modernod.com/news/can-you-catch-covid-19-through-your-eyes/2477840/You can catch COVID-19 if an infected person coughs or sneezes and contagious droplets enter your nose or mouth. But can you become ill if the virus lands in your eyes? Virologist Joseph Fair, PhD, an NBC News contributor, raised that concern when he became critically ill with COVID-19, ac
- New Alcon Program Aims to Help ECPs Tap Into Opportunities in the Dry Eye Market Amid COVID-19 Crisishttps://modernod.com/news/new-alcon-program-aims-to-help-ecps-tap-into-opportunities-in-the-dry-eye-market-amid-covid-19-crisis/2477838/Alcon has launched a new program called “No Reason to Wait: Success Starts Now” aimed at helping eye care professionals (ECPs) better understand the practice and patient benefits of treating the root cause of evaporat
- Coronavirus Testing Machines Are Latest Bottleneck In Troubled Supply Chainhttps://modernod.com/news/coronavirus-testing-machines-are-latest-bottleneck-in-troubled-supply-chain/2477835/Coronavirus testing in the U.S. has run into a number of snags, from a lack of nasal swabs to not enough chemicals needed to run the tests. Now there’s a new bottleneck emerging: A shortage of the machines that process the tests and give results, according to an NPR
- Mynosys Changes Name to Centricity Vision; Names New Leadership Teamhttps://modernod.com/news/mynosys-changes-name-to-centricity-vision-names-new-leadership-team/2477834/Centricity Vision, formerly known as Mynosys Cellular Devices, announced a new executive leadership team, along with a new company name. Centricity Vision reflects the company’s core competency, embodied by its Zepto Precision Cataract Surgery Platform, in creating precise, consistent, vis
- Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Projecthttps://modernod.com/news/gene-therapy-program-at-penn-medicine-joins-aavcovid-vaccine-project/2477832/The Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham for the joint research program. AAVCOVID is a unique gene-based vaccine candidate designed
- A New Law in Laser Physics Could Make Eye Surgery Simplerhttps://modernod.com/news/a-new-law-in-laser-physics-could-make-eye-surgery-simpler/2477830/Scientists have developed a new type of laser that can deliver high amounts of energy in very short bursts of time, with potential applications in eye and heart surgery or the engineering of delicate materials, according to a
- InMed Releases CBN Preclinical Results in Glaucomahttps://modernod.com/news/inmed-releases-cbn-preclinical-results-in-glaucoma/2477826/InMed Pharmaceuticals provided an update on the preclinical results from its INM-088 drug development program that indicate a potential neuroprotective effect of cannabinol (CBN) on nerve cells located in the eye. INM-088 is being developed as a potential treatment option for ocular diseases, suc
- Bausch + Lomb Announces European Launch of a New Platform of Preloaded IOLs, LuxSmart and LuxGoodhttps://modernod.com/news/bausch-lomb-announces-the-launch-of-a-new-platform-of-preloaded-iols-luxsmart-and-luxgood/2477823/Bausch + Lomb announced the European launch of the company’s first presbyopia correcting IOL, LuxSmart, and its monofocal version, LuxGood. Both feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. LuxSmart and LuxGood comprise a hydrophobic material and repres
- Conjunctivitis Can Be Sole COVID-19 Symptomhttps://modernod.com/news/conjunctivitis-can-be-sole-covid-19-symptom/2477817/Acute, non-remitting conjunctivitis may be the only presenting symptom of COVID-19 infections in some instances, according to case reports on five patients in Italy, according to a Reuters report. “Conjunctivitis per se is no